Trace Orthopedics

Executive Summary

Trace Orthopedics is an early-stage medical device company based in Austin, Texas, developing a novel, minimally invasive approach to tendon repair called the Trace Method. The company's needle-based system is designed to reattach partially torn tendons to bone without the need for traditional open or arthroscopic surgery, potentially shifting the treatment paradigm from the operating room to a clinic setting. This approach aims to reduce patient recovery time, complications, and overall healthcare costs. Founded in 2019, Trace Orthopedics is privately held and has not publicly disclosed its funding or valuation. The company targets the large and growing market for tendon repair, which includes common injuries such as rotator cuff tears and Achilles tendon ruptures. If successful, Trace Orthopedics could disrupt the current standard of care by offering a less invasive, more accessible alternative. However, as a private company in early development stages, it faces significant regulatory, clinical, and commercialization hurdles. The company's ability to achieve key milestones, secure funding, and demonstrate safety and efficacy in clinical trials will be critical to its long-term success.

Upcoming Catalysts (preview)

• Q3 2026First-in-human study initiation or results60% success
• Q1 2027FDA 510(k) clearance or Breakthrough Device designation40% success
• Q4 2026Series A or strategic partnership announcement50% success